Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVTR Avantor	$13.07 -3.5%	$13.59	$11.82 ▼ $28.00	$8.91B	1.04	8.13 million shs	7.43 million shs
BLUSF BELLUS Health		$9.77	$0.49 ▼ $2.60	$2.35B	1.55	39,610 shs	3.45 million shs
MASI Masimo	$161.20 -2.5%	$158.44	$101.61 ▼ $194.88	$8.74B	1.19	643,001 shs	547,190 shs
SNPTF Sunny Optical Technology (Group)	$8.29	$7.77	$5.04 ▼ $11.75	$9.08B	0.52	611 shs	N/A

20 Stocks to Sell Now

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVTR Avantor	0.00%	-0.04%	+1.79%	-19.99%	-40.95%
BLUSF BELLUS Health	0.00%	0.00%	0.00%	0.00%	0.00%
MASI Masimo	0.00%	-6.26%	+4.41%	-4.17%	+21.58%
SNPTF Sunny Optical Technology (Group)	0.00%	+7.66%	+0.48%	-29.45%	+37.48%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVTR Avantor	4.7679 of 5 stars	4.2	2.0	0.0	3.2	2.1	3.3	2.5
BLUSF BELLUS Health	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MASI Masimo	4.1003 of 5 stars	3.4	1.0	0.0	4.2	1.3	3.3	1.3
SNPTF Sunny Optical Technology (Group)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVTR Avantor	2.46	Hold	$18.88	44.41% Upside
BLUSF BELLUS Health	0.00	N/A	N/A	N/A
MASI Masimo	2.83	Moderate Buy	$191.60	18.86% Upside
SNPTF Sunny Optical Technology (Group)	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest BLUSF, AVTR, SNPTF, and MASI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/7/2025	MASI Masimo	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$193.00
5/7/2025	MASI Masimo	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$215.00 ➝ $200.00
5/7/2025	MASI Masimo	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$204.00 ➝ $185.00
5/7/2025	MASI Masimo	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$205.00 ➝ $190.00
4/29/2025	AVTR Avantor	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight
4/29/2025	AVTR Avantor	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$23.00 ➝ $14.00
4/28/2025	AVTR Avantor	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
4/28/2025	AVTR Avantor	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Overweight ➝ Equal Weight	$25.00 ➝ $15.00
4/28/2025	AVTR Avantor	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$24.00 ➝ $20.00
4/28/2025	AVTR Avantor	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$18.00 ➝ $15.00
4/28/2025	AVTR Avantor	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$15.50

(Data available from 6/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVTR Avantor	$6.69B	1.33	$1.21 per share	10.76	$8.75 per share	1.49
BLUSF BELLUS Health	$30K	0.00	N/A	N/A	$0.25 per share	0.00
MASI Masimo	$2.13B	4.11	$5.24 per share	30.74	$25.79 per share	6.25
SNPTF Sunny Optical Technology (Group)	$4.48B	2.02	$0.47 per share	17.62	N/A	∞

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVTR Avantor	$711.50M	$1.04	12.57	10.89	1.55	10.49%	12.17%	5.38%	7/25/2025 (Estimated)
BLUSF BELLUS Health	-$7.01M	-$0.10	N/A	N/A	N/A	-49,910.34%	-48.37%	-45.25%	N/A
MASI Masimo	$81.50M	-$9.17	111.17	34.82	N/A	3.85%	14.98%	6.95%	8/5/2025 (Estimated)
SNPTF Sunny Optical Technology (Group)	$155.35M	N/A	0.00	∞	N/A	N/A	N/A	N/A	8/18/2025 (Estimated)

Latest BLUSF, AVTR, SNPTF, and MASI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/6/2025	Q1 2025	MASI Masimo	$1.24	$1.36	+$0.12	-$3.12	$367.79 million	$372.00 million
4/25/2025	Q1 2025	AVTR Avantor	$0.23	$0.23	N/A	$0.09	$1.61 billion	$1.58 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVTR Avantor	N/A	N/A	N/A	N/A	N/A
BLUSF BELLUS Health	N/A	N/A	N/A	N/A	N/A
MASI Masimo	N/A	N/A	N/A	N/A	N/A
SNPTF Sunny Optical Technology (Group)	N/A	N/A	N/A	N/A	N/A

Latest BLUSF, AVTR, SNPTF, and MASI Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/31/2025	SNPTF Sunny Optical Technology (Group)		$0.5320	0.83%	6/5/2025	6/6/2025	6/27/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVTR Avantor	0.54	1.07	0.70
BLUSF BELLUS Health	N/A	13.87	13.87
MASI Masimo	0.50	2.01	1.11
SNPTF Sunny Optical Technology (Group)	0.20	1.76	1.51

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVTR Avantor	95.08%
BLUSF BELLUS Health	N/A
MASI Masimo	85.96%
SNPTF Sunny Optical Technology (Group)	N/A

Insider Ownership

Company	Insider Ownership
AVTR Avantor	1.20%
BLUSF BELLUS Health	24.17%
MASI Masimo	16.90%
SNPTF Sunny Optical Technology (Group)	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVTR Avantor	14,500	681.43 million	672.05 million	Optionable
BLUSF BELLUS Health	10	159.12 million	N/A	Not Optionable
MASI Masimo	6,200	54.22 million	48.35 million	Optionable
SNPTF Sunny Optical Technology (Group)	29,524	1.09 billion	N/A	Not Optionable

BLUSF, AVTR, SNPTF, and MASI Headlines

Recent News About These Companies

Sunny Optical Technology (Group) (OTCMKTS:SNPTF) Stock Price Down 6.7% - Should You Sell?

June 7, 2025 | marketbeat.com

Sunny Optical Technology (Group) Company Limited (OTCMKTS:SNPTF) Announces Dividend of $0.53

June 1, 2025 | marketbeat.com

CMB International Securities Reaffirms Their Buy Rating on Sunny Optical Technology (Group) Co (SNPTF)

March 28, 2025 | markets.businessinsider.com

Sunny Optical Technology (Group) Co (SNPTF) Gets a Buy from DBS

March 26, 2025 | markets.businessinsider.com

Sunny Optical Warns of Market Restructuring on Capacity Glut

March 24, 2025 | msn.com

Sunny Optical Technology (Group) Co (SNPTF) Receives a Buy from DBS

March 24, 2025 | markets.businessinsider.com

Asian Value Stock Picks That Could Be Overlooked In March 2025

March 10, 2025 | finance.yahoo.com

DBS Remains a Buy on Sunny Optical Technology (Group) Co (SNPTF)

February 18, 2025 | markets.businessinsider.com

DBS Keeps Their Buy Rating on Sunny Optical Technology (Group) Co (SNPTF)

February 13, 2025 | markets.businessinsider.com

Positive Outlook for Sunny Optical Technology Amidst Leadership Transition and Strategic Growth Initiatives

November 28, 2024 | markets.businessinsider.com

Sunny Optical Sees Diverse Growth in October Shipments

November 9, 2024 | markets.businessinsider.com

Softbank and NewPhotonics Announce Collaboration on Advanced Photonics Technology for LPO, CPO and All-Optics Switch Fabric Targeting AI-RAN

September 24, 2024 | tmcnet.com

Keysight Technologies to acquire Optical Solutions Group from Synopsys

September 24, 2024 | siliconsemiconductor.net

3 SEHK Stocks That May Be Undervalued In September 2024

September 24, 2024 | finance.yahoo.com

Sunny Optical’s Robust Profit Growth and Market Leadership Justify a Buy Rating

August 27, 2024 | markets.businessinsider.com

Sunny Optical Technology (Group) Company Limited (SXC0.MU)

August 23, 2024 | sg.finance.yahoo.com

Sunny Optical Receives ‘Buy’ Rating Amidst Strong Financial Performance and Strategic Market Positioning

August 22, 2024 | markets.businessinsider.com

DBS Sticks to Their Buy Rating for Sunny Optical Technology (Group) Co (SNPTF)

August 21, 2024 | markets.businessinsider.com

Sunny Optical Technology Group Co Ltd (SNPTF) H1 2024 Earnings Call Transcript

August 21, 2024 | seekingalpha.com

Citi Reaffirms Their Buy Rating on Sunny Optical Technology (Group) Co (SNPTF)

July 22, 2024 | markets.businessinsider.com

Apple Will Tap Sunny Optical for New MacBook Camera Technology, Claims Kuo

July 19, 2024 | techtimes.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLUSF, AVTR, SNPTF, and MASI Company Descriptions

Avantor NYSE:AVTR

$13.07 -0.47 (-3.47%)

Closing price 06/13/2025 03:59 PM Eastern

Extended Trading

$13.12 +0.05 (+0.42%)

As of 06/13/2025 07:56 PM Eastern

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

BELLUS Health OTCMKTS:BLUSF

BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

Masimo NASDAQ:MASI

$161.20 -4.14 (-2.50%)

Closing price 06/13/2025 04:00 PM Eastern

Extended Trading

$159.02 -2.17 (-1.35%)

As of 06/13/2025 07:44 PM Eastern

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Sunny Optical Technology (Group) OTCMKTS:SNPTF

$8.29 0.00 (0.00%)

As of 06/13/2025

Sunny Optical Technology (Group) Company Limited, an investment holding company, engages in designing, researching, developing, manufacturing, and selling optical and optical related products, and scientific instruments. The company's Optical Components segment offers glass spherical and aspherical lenses, handset lens sets, vehicle lens sets, security surveillance lens sets, and other lens sets. Its Optoelectronic Products segment comprise handset camera modules, three dimensional optoelectronic products, vehicle modules, and other optoelectronic modules. The company's Optical Instruments segment includes microscopes and intelligent inspection equipment for testing. Its optoelectronic-related products are used in handsets, digital cameras, vehicle imaging and sensing systems, security surveillance systems, virtual reality/augmented reality, and robots, which are combined with optical, electronic, algorithm, and mechanical technologies. In addition, the company engages in the research and development of infrared and semiconductor technologies; trading of optical instruments and optoelectronics products; property leasing activities; and development, service, and consultation of technology; provision of financing services; and import and export agency services. It operates primarily in the People's Republic of China, rest of Asia, Europe, North America, and internationally. The company was founded in 1984 and is headquartered in Yuyao, China.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time